Conference abstract · 6 Oct 2025
Conference abstractPublished 29 Mar 2016
Type 1 Diabetes (T1D) reversal by neuropeptide therapy– A Phase-1 progress report
University of Toronto, Canada
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Our Diabetes Research Program focused on neuronal elements in T1D pathogenesis. We found that in T1D mouse models as well as patients, 1.) a major subset of autoimmune targets have neuronal derivation; 2.) TRPV1 (transient receptor potential, vanilloid- 1, a Ca++channel) mutations are a core disease-prerequisite, which consequent deficiency of TRPV1-dependent neuropeptides such as substance P (sP). Hypofunctional/hyposecretory mutations in T1D-prone NOD mice have analogs in T1D patients: human TRPV1 (chromosome 17) is polymorphic with possibly thousands of varied alleles, but we found the exclusive presence of the same, 4 alleles in over 50 patients. The sole exception was one T1D patient, carrying non-polymorphic, African TRPV1. Single nucleotide polymorphisms (SNP) Analysis of 1000-Genomes data showed 59 severe SNP mutations TRPV1(2.3%). Remarkably, there were 159 TRPV1 SNPs in our first 21 T1D patients, clustered mainly in 6 of 28 genomic PCR fragments sequenced, and this trend is sustained in 28 additional patients. Collectively, these data emphasize similarities between NOD mice and patients, with TRPV1 clearly a prominent if not the major element. T1D is reversed in NOD mice for months following a single pancreatic sP injection via the celiac artery, a routine medical access route in Interventional Image-Guided therapies (IGT). Recently, substantial reserves of pre-betacells with re-differentiation of functionality were discovered well after T1D onset. Here we describe our approved translational trial, designed to determine if and at what dose sP can reverse human T1D.
Subjects
Paediatrics & NeonatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pediatrics & Therapeutics.
Conference abstract · 6 Oct 2025
Out of Hospital Neonatal Outcomes (OHNO) registry
Conference abstract · 6 Oct 2025
Innovations in Early Diagnosis of Neonatal Sepsis: Advances in Biomarkers and Clinical Protocols
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPediatrics & Therapeutics
- SubjectPaediatrics & Neonatology
- BylineArticles whose byline prints “H Michael Dosch”
